COOPER GRAHAM K 4
4 · Kezar Life Sciences, Inc. · Filed May 13, 2022
Insider Transaction Report
Form 4
COOPER GRAHAM K
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-12+26,000→ 26,000 totalExercise: $5.52Exp: 2032-05-11→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the shares shall vest on a monthly basis commencing on May 12, 2022, subject to the Reporting Person continuing to provide service through each such date.